FDA Announces Joint Meeting of Advisory Committees and Public Comment Period

Summary

The Food and Drug Administration (FDA) is hosting a joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee, where the committees will provide advice on FDA's regulatory issues. The public is invited to attend and the meeting will be open to comments.